Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth (2020)
Source: Gene Therapy. Unidades: ICB, FM
Subjects: BIOLOGIA CELULAR, NEOPLASIAS PROSTÁTICAS, QUIMIOTERAPIA, CÉLULAS CULTIVADAS DE TUMOR, LEUCOPENIA ANIMAL, CAMUNDONGOS, MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAMURA, Rodrigo Esaki et al. Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth. Gene Therapy, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41434-019-0071-x. Acesso em: 04 out. 2024.APA
Tamura, R. E., Lana, M. V. G., Costanzi-Strauss, E., & Strauss, B. E. (2020). Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth. Gene Therapy. doi:10.1038/s41434-019-0071-xNLM
Tamura RE, Lana MVG, Costanzi-Strauss E, Strauss BE. Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth [Internet]. Gene Therapy. 2020 ;[citado 2024 out. 04 ] Available from: https://doi.org/10.1038/s41434-019-0071-xVancouver
Tamura RE, Lana MVG, Costanzi-Strauss E, Strauss BE. Combination of cabazitaxel and p53 gene therapy abolishes prostate carcinoma tumor growth [Internet]. Gene Therapy. 2020 ;[citado 2024 out. 04 ] Available from: https://doi.org/10.1038/s41434-019-0071-x